Policymakers & Community Leaders
Payers & Providers
Patients & Caregivers

Alternative Pain Management Therapies – Minnesota Medicaid Benefit Coverage

Source: Minnesota Department of Human Services

This 2019 patient/provider decision tool lists alternative pain management therapies that may be considered as an alternative to opioids and whether or not listed treatments are covered by Minnesota Medicaid health plans.

Document
Policymakers & Community Leaders
Payers & Providers

State Medicaid Strategies to Promote Early Identification and Treatment of Pregnant Women with Substance Use Disorder

Source: National Academy for State Health Policy

This policy brief from the National Academy for State Health Policy reviews Medicaid strategies for identifying and caring for pregnant women with substance use disorders. The report provides a high-level overview of programs operational in 5 states: Connecticut, Florida, Tennessee, Montana, and Vermont.

Document
Policymakers & Community Leaders
Payers & Providers

State Guidance for Implementation of the Treatment for Infants with Neonatal Abstinence Syndrome in Residential Pediatric Recovery Centers (SUPPORT Act)

Source: Centers for Medicare and Medicaid Services

The 2018 SUPPORT Act passed by Congress directed the Centers for Medicare and Medicaid Services to create a new provider type in Medicaid of “residential pediatric recovery centers” (RPRCs) which treat infants with neonatal opiate withdrawal/neonatal abstinence syndrome. This letter provides guidance for states wishing to add RPRCs as provider types eligible for reimbursement through Medicaid.

Document
Policymakers & Community Leaders
Payers & Providers

State Guidance for the New Limited Exception to the IMD Exclusion for Certain Pregnant and Postpartum Women (SUPPORT Act): Help for Moms and Babies

Source: Centers for Medicare and Medicaid Services

The 2018 SUPPORT Act passed by Congress directed the Centers for Medicare and Medicaid Services to create a exception to the institution for mental disease (IMD) exclusion for certain pregnant and postpartum women. The IMD exclusion forbids the expenditure of federal funding on services provided in facilities with

Document
Payers & Providers

The Impact of 42 CFR Part 2 on Care Coordination by Health Plans for Members with Substance Use Disorders

Source: Association for Community Affiliated Plans

Researchers and health care providers increasingly realize the importance of coordinating a patient’s behavioral and medical health care. Federal regulations under 42 CFR Part 2 require that providers obtain patient consent before sharing information about substance use disorder treatment. This report from the Association for Community Health Plans describes the challenges insurers

Document
Policymakers & Community Leaders

CMS Roadmap: Fighting the Opioid Crisis

Source: Centers for Medicare & Medicaid Services

This 4 page document briefly summarizes the Centers for Medicare & Medicaid Services strategy for fighting the opioid crisis including their initiatives in prevention, treatment, and data analysis.

Document